Investing.com - Phio Pharma reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that was in line with expectations.
Phio Pharma announced earnings per share of $-0.260 on revenue of $12.5M. Analysts polled by Investing.com anticipated EPS of $-0.210 on revenue of $12.50M.
Phio Pharma shares are down 53.92% from the beginning of the year, still down 77.69% from its 52 week high of $2.42 set on April 8.
Phio Pharma follows other major Healthcare sector earnings this month
Phio Pharma's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar